文献速递妇科产科

BRCA1突变女性接受年度超声筛查或预防性卵巢切除术的卵巢癌死亡率比较

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.
PubMed 文献 · Gynecol Oncol · 2019-09-26

前瞻性研究纳入1964名BRCA1突变且卵巢完整的女性,比较接受至少一次超声筛查者与接受预防性卵巢切除术者的生存情况。筛查组10年累积死亡风险为2.0%,手术组为0.5%;预防性卵巢切除术对比超声筛查的风险比为0.23(95%CI:0.05至0.97;p=0.05)。结论认为超声筛查项目确诊的卵巢癌生存率相对较差,筛查不是预防性卵巢切除术的可行替代方案。

要点

  • 预防性卵巢切除术对比超声筛查的死亡风险比为0.23(95%CI:0.05至0.97;p=0.05)。
  • 超声筛查组10年累积死亡风险为2.0%,预防性卵巢切除术组为0.5%。
  • 超声筛查项目确诊的卵巢癌生存率相对较差,筛查不是预防性卵巢切除术的可行替代方案。

核心结论

  • 超声筛查项目确诊的卵巢癌生存率相对较差,筛查不是预防性卵巢切除术的可行替代方案。

研究设计与样本

  • 前瞻性研究纳入1964名BRCA1突变且双侧卵巢完整的女性,研究开始时均无卵巢癌且未行双侧卵巢切除术。
  • 队列中1814名女性至少接受过一次筛查超声,从首次超声日期随访至预防性卵巢切除术、死亡或末次随访。
  • 队列中659名女性接受预防性卵巢切除术,从手术日期随访至死亡或末次随访。

主要发现

  • 1196名接受至少一次超声检查且未行卵巢切除术的女性中,检出73例新发癌症,27例死于卵巢癌或输卵管癌,10年累积死亡风险为2.0%。
  • 659名接受预防性卵巢切除术的女性中,12例新发癌症(9例在卵巢切除术时检出,3例在随访期间检出),2例死于卵巢癌,10年累积死亡风险为0.5%。
  • 预防性卵巢切除术对比超声筛查的风险比为0.23(95%CI:0.05至0.97;p=0.05)。

临床怎么用

  • 原文结论认为超声筛查不是预防性卵巢切除术的可行替代方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare the survival experience of women with a BRCA1 mutation who enrolled in an ovarian cancer screening program with that of women who opted for preventive oophorectomy. METHODS: We followed 1964 women with a BRCA1 mutation and two ovaries intact in a prospective study. No women had ovarian cancer or had a bilateral oophorectomy prior to study initiation. There were 1814 women in the cohort who had at least one screening ultrasound. They were followed from the date of first ultrasound until the date of preventive oophorectomy, death or last follow-up. There were 659 women in the cohort who had preventive oophorectomy. They were followed from the date of preventive oophorectomy until death or last follow-up. RESULTS: Among the 1196 women who had one or more ultrasound examinations and no oophorectomy, there were 73 incident cancers detected and 27 deaths from ovarian/fallopian cancer. The ten year cumulative risk of death was 2.0%. Among the 659 women who had a preventive oophorectomy there were 12 incident cancers (9 detected at oophorectomy and 3 in the follow up period) and two deaths from ovarian cancer. The ten year cumulative risk of death was 0.5%. The hazard ratio for oophorectomy versus ultrasound was 0.23 (95% CI: 0.05 to 0.97; p = 0.05). CONCLUSION: The survival of women diagnosed with ovarian cancer enrolled in an ultrasound screening program is relatively poor and screening is not a viable alternative to preventive oophorectomy.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Gronwald J, Lubinski J, Huzarski T, et al. A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy. Gynecol Oncol. 2019. PMID: 31500890. doi:10.1016/j.ygyno.2019.08.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。